Characterization of Methylation Patterns in Lung Cancer

NCT02373917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 683

Last updated 2021-05-04

No results posted yet for this study

Summary

In this study the investigators will collect Blood,sputum and saliva samples for Characterization of Methylation Patterns in lung Cancer.

Conditions

Sponsors & Collaborators

  • Nucleix Ltd.

    lead INDUSTRY

Principal Investigators

  • Eilon Ganor, MD · Nucleix Ltd.

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373917 on ClinicalTrials.gov